基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 原料药 抗肿瘤药 替尼类抗肿瘤药 二对甲苯磺酸拉帕替尼 二对甲苯磺酸拉帕替尼(GW-572016)
  • aladdin 阿拉丁 L408619 二对甲苯磺酸拉帕替尼(GW-572016) 388082-77-7 10mM in DMSO
  • aladdin 阿拉丁 L408619 二对甲苯磺酸拉帕替尼(GW-572016) 388082-77-7 10mM in DMSO

1/2

aladdin 阿拉丁 L408619 二对甲苯磺酸拉帕替尼(GW-572016) 388082-77-7 10mM in DMSO

Lapatinib (GW-572016) Ditosylate
388082-77-7
165.90 1ml 起订
上海 更新日期:2024-04-22

上海阿拉丁生化科技股份有限公司

VIP1年
联系人:阿拉丁客服
手机:+86-18521732826 拨打
邮箱:market@aladdin-e.com

产品详情:

中文名称:
二对甲苯磺酸拉帕替尼(GW-572016)
英文名称:
Lapatinib (GW-572016) Ditosylate
CAS号:
388082-77-7
品牌:
阿拉丁
产地:
上海
保存条件:
-80℃储存
纯度规格:
10mM in DMSO
产品类别:
药靶配体 药靶配体
分子式:
C29H26ClFN4O4S·2C7H8O3S
分子量:
925.46
运输条件:
超低温冰袋运输
产品规格:
1ml
货号:
L408619
是否进口:

中文名:二对甲苯磺酸拉帕替尼(GW-572016)

英文名:Lapatinib (GW-572016) Ditosylate

英文别名:N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,di4-methylbenzenesulfonate

纯度:10mM in DMSO

货号:L408619

包装:1ml

Cas号:388082-77-7

存储温度:-80℃储存

产品介绍:

Information

Lapatinib (GW-572016) Ditosylate is a potentEGFRandErbB2inhibitor withIC50of 10.8 and 9.2 nM in cell-free assays, respectively.
In vitro

Lapatinib Ditosylate weakly inhibits the activity of ErbB4 with IC50 of 367 nM, and displays >300-fold selectivity for EGFR and ErbB2 over other kinases such as c-Src, c-Raf, MEK, ERK, c-Fms, CDK1, CDK2, p38, Tie-2, and VEGFR2. Lapatinib Ditosylate significantly inhibits receptor autophosphorylation of EGFR and ErbB2 in a dose-dependent manner with IC50 of 170 nM and 80 nM, respectively in HN5 cells; as well as 210 nM and 60 nM, respectively in BT474 cells. Unlike OSI-774 and Iressa (ZD1839) which preferentially inhibit the growth of the EGFR-overexpressing cells, Lapatinib Ditosylate inhibits the growth of both EGFR- and ErbB2-overexpressing cells. Lapatinib Ditosylate displays higher inhibitory activity against EGFR- or ErbB2-overexpressing cells with IC50 of 0.09-0.21 μM, compared with cells expressing low levels of EGFR or ErbB2 with IC50 of 3-12 μM, and exhibits ~100-fold selectivity over the normal fibroblast cells. Lapatinib Ditosylate potently inhibits the outgrowth of EGFR-overexpressing HN5 and A-431 cells, as well as ErbB2-overexpressing BT474 and N87 cells, and significantly induces G1 arrest of HN5 cells and apoptosis of BT474 cells, which are associated with inhibition of AKT phosphorylation.

In vivo

Oral administration of Lapatinib Ditosylate (~100 mg/kg) twice daily significantly inhibits the growth of BT474 and HN5 xenografts in a dose-dependent manner.
Cell Data

cell lines:

Concentrations:Dissolved in DMSO, final concentrations ~100 μM

Incubation Time:72 hours

Powder Purity:≥99%

查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/L408619.html


N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,di4-methylbenzenesulfonate

公司简介

上海阿拉丁生化科技股份有限公司是A股上市公司((股票代码:688179),专注于科研试剂的研发、生产和销售,已陆续建立多个工厂和研发中心。作为领军企业,阿拉丁始终坚持质量第一,连续13年被评为“最受欢迎试剂品牌”。 阿拉丁目前常备库存试剂产品品种超过7万种,SKU总数超过46万,产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域,是国内少数化学试剂到生物试剂全面发展的国产试剂品牌,产品同步发布在我们国内外电商平台。

成立日期 (16年)
注册资本 14130.676万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 生物化工,化学试剂

二对甲苯磺酸拉帕替尼(GW-572016)相关厂家报价 更多

内容声明
拨打电话 立即询价